Tirzepatide has emerged as a groundbreaking therapy for type 2 diabetes, offering promising results. However, the cost of this innovative drug and its availability have become key concerns for patients and healthcare professionals. While tirzepatide has been approved by regulatory agencies, its expensive nature presents a significant obstacle to m